
Keywords: Rotavirus; Vaccine; National immunization program; AGE; acute gastroenteritis; GSK; GlaxoSmithKline; HRV; human rotavirus vaccine; HBRV; human-bovine reassortant rotavirus vaccine; RRV-TV; tetravalent rhesus-human rotavirus vaccine; RVGE; rotavirus gastro